Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Headache after traumatic brain injury

In one third of those affected, they remain forever

    • Neurology
    • RX
    • Studies
  • 3 minute read

Every year, more than 400,000 people in Germany suffer a traumatic brain injury, which can range from a mild concussion to fractures of the skull bone. The most common symptom of traumatic brain injury is headache – and it doesn’t always go away after the acute injury phase. In up to one third of those affected, the headaches become chronic, i.e. they persist for months or even years after the accident. The causes of this are only gradually being understood.

The fact that people who have suffered an impact on the head develop acute headaches is often considered a normal and temporary phenomenon, even by doctors. Often, therefore, targeted treatment only kicks in when the pain does not go away even after a few weeks – by definition, a post-traumatic headache is considered chronic if it persists for more than three months. “However, this significantly underestimates the problem,” says PD Dr. med. Torsten Kraya, head physician at the Clinic for Neurology at Klinikum St. Georg in Leipzig and congress president of the German Pain Congress 2022. Today, it is assumed that the course for the later development of headache symptoms is already set in the acute phase after the traumatic brain injury.

But how do headaches develop in the first place? Visible tissue injuries, such as bleeding or fractures, are often not present in mild traumatic brain injury. Nevertheless, the shock to which the brain is subjected has far-reaching consequences: As recent research shows, the permeability of nerve cell membranes changes abruptly under mechanical stress, resulting in a whole cascade of changes in ionic currents, signaling substances, neuronal activity, cell metabolism, and regional blood flows in the brain. The release of pro-inflammatory substances also appears to play a role in the development of pain. “These acute changes return to normal within a few days or weeks,” Kraya says. It is still not fully understood why pain persists in some people. Presumably, permanent changes in pain perception, the body’s own pain-inhibiting systems, and a dysbalance of the autonomic nervous system, which controls heart rate, respiratory rate, and blood flow, among other things, played a role here. This could also be the cause of many other complaints that can occur after a traumatic brain injury, such as sleep disorders, depression or anxiety disorders. 

A post-traumatic headache of the migraine type is often treated with triptans, while tension headaches are more likely to be treated with aspirin, paracetamol or ibuprofen. Often there are also mixed forms. However, in addition to the choice of medication, the timing of treatment also appears to be critical. “Once the pain takes on a life of its own, it’s very difficult to manage,” Kraya says. Therefore, the tendency today is to take countermeasures with medication as early as possible – especially in patients who have risk factors for chronic pain. These include a pre-existing tendency to headache, younger age, female gender, and migraine-type headache. “Studies also indicate that moderate physical and mental activation is useful as early as 24 or 48 hours after the accident, in part to avoid practicing restraint behaviors and chronicity of pain,” Kraya says. Persons with an increased risk of chronicity should therefore ideally be treated with a multimodal therapy approach, which, in addition to early pain therapy, also includes behavioral therapy elements and, under certain circumstances, targeted activation through physiotherapy.

 

Original publication:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203551/ 

Previous Article
  • Interventional therapy methods

Focus on functional mitral valve regurgitation

  • Cardiology
  • Congress Reports
  • RX
  • Studies
  • Surgery
View Post
Next Article
  • Immunoadsorption (IA)

Advantages over methylprednisolone in MS patients

  • Neurology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 3 min
  • Antisense oligonucleotide for severe hypertriglyceridemia

Reduced Incidence of Acute Pancreatitis

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 5 min
  • Hereditary Transthyretin Amyloidosis with Polyneuropathy

New Treatment Options for ATTRv-PN

    • RX
    • Cardiology
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Studies
View Post
  • 7 min
  • Type 1 Diabetes: A New Disease-Modifying Treatment Approach

Slowing the loss of β-cell function and delaying the progression of the disease

    • RX
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Pediatrics
    • Studies
View Post
  • 6 min
  • Liver Cancer

Artificial Intelligence in Precision Oncology—Opportunities and Challenges

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • Oncology
    • Studies
View Post
  • 6 min
  • Acute nonspecific back pain

Implementing a biopsychosocial approach

    • RX
    • Congress Reports
    • General Internal Medicine
    • Orthopedics
    • Physical medicine and rehabilitation
    • Studies
    • Surgery
    • Traumatology and trauma surgery
View Post
  • 9 min
  • Psychedelic-assisted therapy

Current status of PAT

    • RX
    • CME continuing education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 10 min
  • Neuropathic Pain

Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data

    • RX
    • CME continuing education
    • Neurology
    • Physical medicine and rehabilitation
    • Studies
    • Surgery
View Post
  • 14 min
  • Fibromyalgia Syndrome

Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity

    • General Internal Medicine
    • CME continuing education
    • Geriatrics
    • Neurology
    • Orthopedics
    • Rheumatology
    • RX
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
  • 2
    Current status of PAT
  • 3
    Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
  • 4
    Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.